UBS Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,100
Closed -$289K 9091
2021
Q1
$289K Sell
12,100
-29,609
-71% -$707K ﹤0.01% 4271
2020
Q4
$609K Buy
41,709
+10,902
+35% +$159K ﹤0.01% 3542
2020
Q3
$437K Sell
30,807
-15,236
-33% -$216K ﹤0.01% 3525
2020
Q2
$677K Sell
46,043
-19,042
-29% -$280K ﹤0.01% 3153
2020
Q1
$268K Sell
65,085
-26,592
-29% -$109K ﹤0.01% 3680
2019
Q4
$441K Buy
91,677
+31,044
+51% +$149K ﹤0.01% 3994
2019
Q3
$367K Buy
60,633
+44,902
+285% +$272K ﹤0.01% 3940
2019
Q2
$102K Buy
15,731
+8,621
+121% +$55.9K ﹤0.01% 4524
2019
Q1
$50K Sell
7,110
-16,894
-70% -$119K ﹤0.01% 4745
2018
Q4
$116K Buy
24,004
+6,636
+38% +$32.1K ﹤0.01% 4545
2018
Q3
$128K Buy
17,368
+5,773
+50% +$42.5K ﹤0.01% 4516
2018
Q2
$74K Buy
11,595
+10,768
+1,302% +$68.7K ﹤0.01% 4788
2018
Q1
$5K Sell
827
-4,029
-83% -$24.4K ﹤0.01% 6375
2017
Q4
$20K Buy
4,856
+2,208
+83% +$9.09K ﹤0.01% 5605
2017
Q3
$25K Buy
2,648
+348
+15% +$3.29K ﹤0.01% 5405
2017
Q2
$27K Sell
2,300
-1,080
-32% -$12.7K ﹤0.01% 5153
2017
Q1
$43K Sell
3,380
-5,327
-61% -$67.8K ﹤0.01% 4734
2016
Q4
$106K Buy
8,707
+3,876
+80% +$47.2K ﹤0.01% 4368
2016
Q3
$57K Sell
4,831
-2,114
-30% -$24.9K ﹤0.01% 4549
2016
Q2
$60K Buy
6,945
+6,245
+892% +$54K ﹤0.01% 4536
2016
Q1
$4K Sell
700
-385
-35% -$2.2K ﹤0.01% 6258
2015
Q4
$8K Sell
1,085
-11,615
-91% -$85.6K ﹤0.01% 6137
2015
Q3
$100K Sell
12,700
-9,500
-43% -$74.8K ﹤0.01% 4220
2015
Q2
$201K Buy
22,200
+1,000
+5% +$9.05K ﹤0.01% 3868
2015
Q1
$275K Sell
21,200
-2,841
-12% -$36.9K ﹤0.01% 3590
2014
Q4
$327K Buy
+24,041
New +$327K ﹤0.01% 3470